Let’s keep some perspective here. There’s a lo
Post# of 88045

What actually matters here—and what changes everything—is the merger or acquisition itself. When a private company merges into UNVC, that event alone redefines the valuation and trajectory. We’re talking about an operation that has already managed significant contracts and partnerships within healthcare—activity that has taken place long before any public reporting requirement. Once that private structure folds in, the market will recognize the true scale of what’s been built behind the scenes.
A merger triggers a public disclosure within four business days of closing, not during negotiations. Until that point, silence isn’t evidence of inactivity; it’s compliance and strategy.
The assumption that nothing can move forward because of an audit or PCAOB timeline misses the bigger picture. Companies often finalize mergers before uplisting, then proceed with audited financials once integration is complete. That’s a normal sequence.
So while some are fixated on whether the company uplists immediately, that’s secondary. The real inflection point will come when the private entity merges into UNVC—and that’s where the value and price per share acceleration begin. Uplisting may follow in due course, but it’s not the prerequisite for success.
We’re watching a long-term build that’s closer to its next stage than most realize. No need for hype, but no reason to discount what’s already in motion either.

